Lantern Pharma Inc.
Leverages AI and machine learning to discover and develop targeted cancer therapies.
LTRN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US51654W1018
- LEI:
- Country:
- United States of America
- Address:
- 1920 MCKINNEY AVENUE, 75201 DALLAS
- Website:
- https://www.lanternpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Lantern Pharma is a clinical-stage pharmaceutical company focused on oncology. The company aims to transform the cost, pace, and timeline of cancer drug discovery and development by leveraging its proprietary artificial intelligence (AI) and machine learning (ML) platform. This platform utilizes advanced genomics and large-scale data analysis to identify patient-specific biomarkers and develop targeted cancer therapies. By applying a data-driven, precision-medicine approach, Lantern Pharma seeks to de-risk the drug development process and increase the likelihood of successful clinical outcomes for its pipeline of oncology drug candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lantern Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lantern Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lantern Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
